Joseph W Kim

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Respiratory Syndrome Coronavirus

Circulating Tumor

Top Venues

JCO precision oncology

Current oncology reports

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Yiduo Hu, Azeet Narayan, Yunshan Xu, Julia Wolfe, Dennis Vu, Thi Trinh, Chaitanya Kantak, Susan Percy Ivy, Joseph Paul Eder, Yanhong Deng, Patricia LoRusso, Joseph W Kim, Abhijit A Patel
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors. JCO precision oncology 8 (2024)
Yiduo Hu, Azeet Narayan, Yunshan Xu, Julia Wolfe, Dennis Vu, Thi Trinh, Chaitanya Kantak, Susan Percy Ivy, Joseph Paul Eder, Yanhong Deng, Patricia LoRusso, Joseph W Kim, Abhijit A Patel
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors. JCO precision oncology 8 (2024)
Yiduo Hu, Azeet Narayan, Yunshan Xu, Julia Wolfe, Dennis Vu, Thi Trinh, Chaitanya Kantak, Susan Percy Ivy, Joseph Paul Eder, Yanhong Deng, Patricia LoRusso, Joseph W Kim, Abhijit A Patel
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors. JCO precision oncology 8 (2024)
Yiduo Hu, Azeet Narayan, Yunshan Xu, Julia Wolfe, Dennis Vu, Thi Trinh, Chaitanya Kantak, Susan Percy Ivy, Joseph Paul Eder, Yanhong Deng, Patricia LoRusso, Joseph W Kim, Abhijit A Patel
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors. JCO precision oncology 8 (2024)
Serhan Unlu, Joseph W Kim
Emerging Role of PARP Inhibitors in Metastatic Prostate Cancer. Current oncology reports 24 (11) (2022)
Serhan Ünlü, Junghee Jenny Shin, Jennefer Par-Young, Michael Simonov, Joseph Vinetz, Daniel P Petrylak, Insoo Kang, Joseph W Kim
Effect of Androgen-Androgen Receptor Directed Therapy on COVID-19 Outcome in Prostate Cancer Patients. Cancer investigation (2022)
Joseph W Kim, Rana R McKay, Marc R Radke, Shilin Zhao, Mary-Ellen Taplin, Nancy B Davis, Paul Monk, Leonard J Appleman, Primo N Lara, Ulka N Vaishampayan, Jingsong Zhang, Asit K Paul, Glenn Bubley, Eliezer Van Allen, Serhan Ünlü, Ying Huang, Massimo Loda, Geoffrey I Shapiro, Peter M Glazer, Patricia M LoRusso, Susan Percy Ivy, Yu Shyr, Elizabeth M Swisher, Daniel P Petrylak
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Joseph W Kim, Dana B Cardin, Ulka N Vaishampayan, Shumei Kato, Steven R Grossman, Peter M Glazer, Yu Shyr, S Percy Ivy, Patricia M LoRusso
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation. The oncologist 26 (7) (2021)